BHA publish Notice – International Residue Limits – Bufotenine and DMT
The British Horseracing Authority (BHA) would like to advise the Responsible Person (i.e. trainers, owners, breeders) and their veterinary surgeons of two International Residue Limits for Bufotenine and DMT, which will be effective on 01 January 2019. The notice is available in the Downloads section of the Members area.
BHA Survey – BHA seek opinions on Firing and Blistering
British Racing – Firing and Blistering Survey - BHA seek your opinion The International Federation of Horseracing Authorities (IFHA) have proposed and passed recommendations regarding firing and blistering. At present, the BHA has not signed up to either recommendation. As the Director of Equine Health and Welfare for the British Horseracing Authority (BHA) and your representative for British racing on the IFHA Welfare Committee, David Sykes has written to equine veterinary surgeons that are involved in treating racing thoroughbreds in the UK to ask whether you would support either, or both, of these recommendations. Mr. Sykes said: "Following the focus placed on racehorse welfare during the
Scientific research into equine vision leads to trial of new fence and hurdle design to further improve safety in jump racing
- Research by University of Exeter shows that horses see better and may jump differently over white and yellow obstacles compared to the orange currently used on hurdles and fences
- Recommendation to trial the use of fluorescent yellow for all hurdles and guard-rails, and fluorescent white for take-off boards at fences approved by Racecourse Committee
- Trial will be rolled out first at training yards before being used in a live racing environment, and has the objective of making jump racing safer for horse and rider
- Research to be shared with other jurisdictions and equine pursuits
BHA issue notice, regarding Regumate Equine, to British racehorse Trainers
On 11 September the BHA published a Notice regarding the use of products which contain altrenogest – a copy of this notice can be found on the BHA website.
At the time of publication, the BHA obtained samples from several different batch numbers of Regumate® Equine 2.2mg/ml Oral Solution for Horses (MSD Animal Health) and requested analysis of these samples from LGC, our partner analytical laboratory. The results of this analysis detected the presence of trendione in the above batches of Regumate® Equine.
British Horseracing Authority Notice regarding use of Altrenogest
The BHA would like to make Trainers, veterinary surgeons and other industry participants aware of an international issue regarding products which contain altrenogest. Altrenogest is commonly referred to by the trade name “Regumate”.
RCA provide updated document on Prevention of Heat Stress in Racehorses
In light of the ongoing hot weather conditions, the RCA have updated Section 2 of the RCA Veterinary Guidance Documents, regarding the prevention and treatment of heat stress in horses.
BHA Publish Notice providing guidance on Stand-Down Periods for Bisphosphonates
The British Horseracing Authority has published a notice to provide guidance on the Stand-Down Period for Bisphosphonates, in relation to gamma scintigraphy (bone scan) and the use of bisphosphonates in horses under the age of three and a half years.
BHA Director of Equine Health & Welfare clarifies methods of equine euthanasia at race meetings
David Sykes, Director of Equine Health and Welfare at the British Horseracing Authority clarifies the use of a firearm for the euthanasia of any horse at a race meeting run under the BHA Rules of Racing.
Amendments to the Rules of Racing – Cyclosporine Implants
Amendments to the Rules of Racing - Cyclosporine Implants; effective from 2 April 2018.
Amendments to the Rules of Racing – Manipulative Therapy
Amendments to the Rules of Racing - Manipulative Therapy; effective from 2 April 2018.